healing

KLOW

Also known as KLOW blend, GHK-Cu/BPC-157/TB-500/KPV blend

Four-peptide blend: GLOW (GHK-Cu, BPC-157, TB-500) plus the anti-inflammatory tripeptide KPV.

Medical status: Not approved as a medicine; sold as a research blend.

Also commonly used for (off-label)

  • Recovery where inflammation is part of the picture
  • Skin, hair and connective-tissue repair
  • Gut and inflammatory complaints (via the KPV component)

Off-label and research uses are what people report, not approved indications. Talk to a clinician before using any of them.

How it's taken (route)

Documented dose
2300–2700 mcg
Typical frequency
Once daily, subcutaneous
Cycle
6 weeks on, 4 off
Half-life
Varies by component (GHK-Cu ~1 hour, BPC-157 ~4 hours)
Common vial sizes
80 mg, 100 mg
Regulatory status
Not approved for human use; sold as a research compound.

Dose on a U-100 syringe (2300–2700 mcg)

VialBAC waterDraw
80 mg3 mL8.6–10 units
80 mg5 mL14–17 units
100 mg3 mL6.9–8.1 units
100 mg5 mL12–14 units

On a U-100 syringe, 100 units = 1 mL, and the syringe holds 100 units total. Most people keep a single subcutaneous injection under about 50 units — bigger volumes are usually mixed stronger (less water) or split into two shots. Only mixes that fit in one syringe are shown. Always double-check with the reconstitution calculator.

What it does

KLOW is GLOW with KPV added. The first three peptides cover collagen remodelling, soft-tissue repair and cell migration, while KPV adds an anti-inflammatory arm. It is usually chosen over GLOW when inflammation is part of the picture.

Mechanism

GHK-Cu drives collagen and skin-remodelling gene expression, BPC-157 supports angiogenesis and connective-tissue repair, TB-500 regulates actin and cell motility, and KPV (Lys-Pro-Val, an alpha-MSH fragment) inhibits NF-kB inflammatory signalling. The four-peptide combination itself has not been studied in humans.

Storage — lyophilisedwhat's this?

Refrigerate 2-8C, protect from light.

Storage — reconstitutedwhat's this?

Refrigerate 2-8C, use within ~28 days.

Reconstitution noteswhat's this?

The standard vial is 80 mg (50 mg GHK-Cu + 10 mg each of BPC-157, TB-500 and KPV). Common mix: 80 mg vial + 3 ml bacteriostatic water = about 26.7 mg/ml, so 1 unit on a U-100 syringe (0.01 ml) is roughly 267 mcg of total blend (~167 mcg GHK-Cu and ~33 mcg of each of the others). Ratios vary by supplier — read the label.

Commonly stacked with

  • Wolverine stack (BPC-157 + TB-500)

Commonly reported side effects

  • Injection-site stinging or redness
  • Blue discolouration at the injection site
  • Lightheadedness
  • Nausea

Contraindications noted

  • Wilson disease or copper overload
  • Active malignancy (theoretical, via angiogenesis)
  • Pregnancy or breastfeeding

Research notes

Copper accumulation from the large GHK-Cu load is the usual reason for the 2-4 week off period. No published trial has evaluated the four-peptide combination. BPC-157 and TB-500 are WADA-prohibited for athletes.

Vendors carrying KLOW

These research suppliers list this compound. Prices, vial sizes and testing vary — always check the current lot certificate before you buy.

Peptide Streak users get 15% off PeptideMaxxing with code PEPSTREAK.

Peptide Streak users get 15% off Zeptix Labs with code PEPSTREAK.

Peptide Streak does not sell peptides and is not affiliated with these vendors. Some list metabolic compounds under coded product names.

Track this properly

Work out syringe units with the calculator, or set up a full schedule in about a minute.

Reference information only, not medical advice. See our medical disclaimer.